SYNLOGIC, INC.
SYBX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527599
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
1
- −1 vs. Q1 2026
- Total value $16.66K
Superinvestors holding SYBX
0
- None of the superinvestors held SYBX at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by SYBX insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 20264:09 PM ET | Jul 27, 2026 | SANDELL SCOTT D and 5 othersDirector, 10% Owner | PPurchaseCommon Stock · Derivative | +2.64M | – | – | 2.64M | – | SEC |
| Oct 31, 2025 | Oct 29, 2025 | Dooley Mary BethSee Remarks below | SSaleCommon Stock | −157 | $1.81 | −$284.17 | 12.74K | −1.2% | SEC |
| Apr 3, 2025 | Apr 2, 2025 | Dooley Mary BethSee Remarks below | SSaleCommon Stock | −144 | $1.20 | −$172.8 | 12.9K | −1.1% | SEC |
| Feb 4, 2025 | Feb 3, 2025 | Dooley Mary BethSee Remarks below | SSaleCommon Stock | −2.11K | $1.33 | −$2.8K | 13.05K | −13.9% | SEC |
| Oct 30, 2024 | Oct 29, 2024 | Dooley Mary BethHead of Finance | SSaleCommon Stock | −79 | $1.40 | −$110.6 | 15.15K | −0.5% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in SYBX at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DRW Securities, LLC | 23,763 | $16.66K | 0.00% | 00.0% | Unchanged |